Latest Cost Management News

Page 92 of 103
Dreadnought Resources reported a challenging quarter with significant exploration spending and a tight cash position, yet remains confident in its operational outlook and funding prospects.
Maxwell Dee
Maxwell Dee
31 Jan 2025
Carly Holdings Limited has reported a 41% jump in customer receipts and its highest-ever subscription revenue in the December 2024 quarter, alongside significant cost reductions and strategic fleet adjustments.
Victor Sage
Victor Sage
31 Jan 2025
RooLife Group (ASX: RLG) reported a striking 144% increase in sales revenue for Q2 FY2025, driven by the launch of new online stores across China, Hong Kong, Australia, and India. The company is investing heavily in product development and marketing to capitalize on booming health and wellness markets.
Victor Sage
Victor Sage
31 Jan 2025
Elsight reported a robust 32% increase in annual revenue for 2024, driven by a strategic pivot towards the defense sector, which now accounts for over half of its total revenue. The company’s expanding customer base and debt elimination position it well for growth in 2025.
Sophie Babbage
Sophie Babbage
31 Jan 2025
iCandy Interactive reports a remarkable 105% increase in net cash flow for Q4 2024 despite a 22% drop in cash receipts, driven by strategic expansions and operational efficiencies amid ongoing legal disputes.
Victor Sage
Victor Sage
31 Jan 2025
Lykos Metals Limited reports significant high-grade mineral findings at its Sinjakovo Project and extends its Jezero exploration permit, alongside key board appointments and cost restructuring.
Maxwell Dee
Maxwell Dee
31 Jan 2025
Inventis Limited reported robust Q2 progress with over $5.7 million in confirmed orders and a $2.5 million capital raise underway in the US, signaling strong momentum in its technology-driven growth strategy.
Sophie Babbage
Sophie Babbage
31 Jan 2025
Freehill Mining has reported a record-breaking December quarter with gross sales doubling to $954,000 and a significant improvement in operating cash flow, positioning the company for sustained growth in 2025.
Maxwell Dee
Maxwell Dee
31 Jan 2025
ReNu Energy reports progress on a management buyout proposal for its hydrogen subsidiary and completes sale of legacy geothermal assets, signaling a strategic pivot and ongoing capital challenges.
Maxwell Dee
Maxwell Dee
31 Jan 2025
Chimeric Therapeutics has dosed the first three patients in its Phase 1/2 CHM CDH17 CAR-T trial targeting gastrointestinal cancers, alongside advancing its AML and NK cell therapy programs. The company also secured $5 million in funding and appointed Dr Rebecca McQualter as CEO.
Ada Torres
Ada Torres
31 Jan 2025
Vectus Biosystems reports completion of Phase Ib trials for its lead drug VB0004 and a robust cash position bolstered by a significant R&D tax refund, setting the stage for licensing discussions.
Ada Torres
Ada Torres
31 Jan 2025
Peninsula Energy Limited reported a substantial cash outflow in the December 2024 quarter, driven by significant investing activity related to its Lance Projects. The company is actively pursuing additional funding to support upcoming production scale-up.
Maxwell Dee
Maxwell Dee
31 Jan 2025